Andrew Conway Ivy, who ranks high among U.S. physiologists and still higher as a vice president of the University of Illinois and booster of its medical schools, was on the spot last winter. For 18 months, he had been doing hush-hush research with a drug named Krebiozen which seemed to have helped a few cancer patients for a while. He wanted to go on and find out whether Krebiozen was really valuable, and that would take years.
But Krebiozen is no ordinary drug. It is a secret concoction from the blood of horses, made...
To continue reading:
or
Log-In
